This book examines the implications of Confucian moral and ontological understandings for medical decision-making, human embryonic stem cell research, and health care financing. The book reveals East Asian attitudes on the moral status of human embryos and the morality of embryonic stem cell research that are quite different from Christian and Muslim cultural perspectives. The book also discusses how Confucian cultural resources can help meet the challenges of health care financing.

In the wake of the Charlie Gard and Alfie Evans cases, a wide-ranging international conversation was started regarding alternative thresholds for intervention and the different balances that can be made in weighing up the rights and interests of the child, the parent's rights and responsibilities and the role of medical professionals and the courts. This collection provides a comparative perspective on these issues by bringing together analysis from a range of jurisdictions across Europe, North and South America, Africa and Asia. Contextualising the differences and similarities, and drawing out the cultural and social values that inform the approach in different countries, this volume is highly valuable to scholars across jurisdictions, not only to inform their own local debate on how best to navigate such cases, but also to foster inter-jurisdictional debate on the issues. The book brings together commentators from the fields of law, medical ethics, and clinical medicine across the world, actively drawing on the view from the clinic as well as philosophical, legal and sociological perspectives on the crucial question of who should decide about the fate of a child suffering from a serious illness. In doing so, the collection offers comprehensive treatment of the key questions around whether the current best interests approach is still appropriate, and if not, what the alternatives are. It engages head-on with the concerns seen in both the academic and popular literature that there is a need to reconsider the orthodoxy in this area.

Dr. Reznik's new book shows what goes on behind the scenes of current medical care and how it impacts the patient. He also offers possible solutions for outpatient, inpatient, preventive, and end-of-life care settings.

This volume addresses the proper character of patient informed consent to medical treatment and clinical research. The goal is critically to explore the current individually oriented approach to informed consent which grew out of the dominant bioethics movement that arose in the United States in the 1970s. In contrast to that individually oriented approach, this volume explores the importance of family-oriented approaches to informed consent for medical treatment and clinical research. It draws on both East Asian moral resources as well as a critical response to the ways in which the practice of informed consent has developed in the United States

Human population genetic research (HPGR) seeks to identify the diversity and variation of the human genome and how human group and individual genetic diversity has developed. This book asks whether developing countries are well prepared for the ethical and legal conduct of human population genetic research, with specific regard to vulnerable target group protection. The book highlights particular issues raised by genetic research on populations as a whole, such as the potential harm specific groups may suffer in genetic research, and the capacity for current frameworks of Western developed countries to provide adequate protections for these target populations. Using The People’s Republic of China as a key example, Yue Wang argues that since the target groups of HPGR are almost always from isolated and rural areas of developing countries, the ethical and legal frameworks for human subject protection need to be reconsidered in order to eliminate, or at least reduce, the vulnerability of those groups. While most discussion in this field focuses on the impact of genetic research on individuals, this book breaks new ground in exploring how the interests of target groups are also seriously implicated in genetic work. In evaluating current regulations concerning prevention of harm to vulnerable groups, the book also puts forward an alternative model for group protection in the context of human population genetic research in developing countries. The book will be of great interest to students and academics of medical law, ethics, and the implications of genetic research.

In this book the author explores the shifting philosophical boundaries of modern medical knowledge and practice occasioned by the crisis of quality-of-care, especially in terms of the various humanistic adjustments to the biomedical model. To that end he examines the metaphysical, epistemological, and ethical boundaries of these medical models. He begins with their metaphysics, analyzing the metaphysical positions and presuppositions and ontological commitments upon which medical knowledge and practice is founded. Next, he considers the epistemological issues that face these medical models, particularly those driven by methodological procedures undertaken by epistemic agents to constitute medical knowledge and practice. Finally, he examines the axiological boundaries and the ethical implications of each model, especially in terms of the physician-patient relationship. In a concluding Epilogue, he discusses how the philosophical analysis of the humanization of modern medicine helps to address the crisis-of-care, as well as the question of “What is medicine?” The book’s unique features include a comprehensive coverage of the various topics in the philosophy of medicine that have emerged over the past several decades and a philosophical context for embedding bioethical discussions. The book’s target audiences include both undergraduate and graduate students, as well as healthcare professionals and professional philosophers. “This book is the 99th issue of the Series Philosophy and Medicine...and it can be considered a crown of thirty years of intensive and dynamic discussion in the field. We are completely convinced that after its publication, it can be finally said that undoubtedly the philosophy of medicine exists as a special field of inquiry.”

本书阐述了作者“重构”儒家生命伦理学的主张，从儒家的家庭主义、社会责任、环境伦理、道德之善与礼乐教化等角度全面审视了西方理论的问题，并提出了儒家思想的解决之道。

This book analyses the barriers to, and facilitators of, evidence-based decision making in OECD health-care systems.

Much research has focused on the basic cellular and molecular biological aspects of stem cells. Much of this research has been fueled by their potential for use in regenerative medicine applications, which has in turn spurred growing numbers of translational and clinical studies. However, more work is needed if the potential is to be realized for improvement of the lives and well-being of patients with numerous diseases and conditions. This book series 'Cell Biology and Translational Medicine (CBTMED)' as part of SpringerNature’s longstanding and very successful Advances in Experimental Medicine and Biology book series, has the goal to accelerate advances by timely information exchange. Emerging areas of regenerative medicine and translational aspects of stem cells are covered in each volume. Outstanding researchers are recruited to highlight developments and remaining challenges in both the basic research and clinical arenas. This current book is the tenth volume of a continuing series.

Akira Akabayashi presents the first book to explore the conversation on bioethics that is taking place between scholars and practitioners from the East and West: the first book in the discipline of bioethics for the globalized world of the future. An international team of experts address emerging issues in bioethics, focus on new developments and their potential for change, and set the agenda for the future. Most studies in bioethics advocating East-West dialogue have either attempted cross-cultural comparisons or have proposed Eastern philosophical paradigms to counter Western ideas. The tacit premise of previous work on the East-West dialogue is therefore a strain of relativism. Simply maintaining a respectful distance from other cultures is no longer sufficient in this era of globalization. The time has come for active engagement among different cultural perspectives. The Future of Bioethics initiates discussion on bioethical issues that arise from new medical technologies such as regenerative medicine, enhancement, research ethics, and synthetic biology, and goes on to address challenging dilemmas that result from the globalization of social change, such as transplantation tourism, public health ethics, care in the aging society, and professionalism. The volume presents original work by leading researchers in the field, alongside that of promising new scholars; as such, it establishes not only a cross-cultural dialogue, but dialogue between researchers of different generations. The book is divided into two parts—the first on the progress of biomedical technologies and ethics, and the second on globalization and bioethics. Each part contains four sections on different topics, which feature a lead essay followed by a set of commentaries and further discussion.